Mezentseva M - Search Results

1

Biocompatible SWCNT Conductive Composites for Biomedical Applications.

Markov A, Wördenweber R, Ichkitidze L, Gerasimenko A, Kurilova U, Suetina I, Mezentseva M, Offenhäusser A, Telyshev D. Markov A, et al. Among authors: mezentseva m. Nanomaterials (Basel). 2020 Dec 11;10(12):2492. doi: 10.3390/nano10122492. Nanomaterials (Basel). 2020. PMID: 33322503 Free PMC article.

2

Interfaces Based on Laser-Structured Arrays of Carbon Nanotubes with Albumin for Electrical Stimulation of Heart Cell Growth.

Gerasimenko AY, Kitsyuk E, Kurilova UE, Suetina IA, Russu L, Mezentseva MV, Markov A, Narovlyansky AN, Kravchenko S, Selishchev SV, Glukhova OE. Gerasimenko AY, et al. Among authors: mezentseva mv. Polymers (Basel). 2022 May 2;14(9):1866. doi: 10.3390/polym14091866. Polymers (Basel). 2022. PMID: 35567036 Free PMC article.

3

The Inhibitory Activity of Lactobacillus plantarum Supernatant against Enterobacteria, Campylobacter, and Tumor Cells.

Danilova TA, Adzhieva AA, Mezentseva MV, Suetina IA, Danilina GA, Minko AG, Dmitrieva ML, Zhukhovitsky VG. Danilova TA, et al. Among authors: mezentseva mv. Bull Exp Biol Med. 2023 Nov;176(1):64-67. doi: 10.1007/s10517-023-05969-x. Epub 2023 Dec 13. Bull Exp Biol Med. 2023. PMID: 38091142

4

Cell Interferon Sensitivity in Immunodeficiencies, Autoimmune and Allergic Diseases.

Narovlyansky AN, Amchenkova AM, Mezentseva MV, Sanin AV, Ershov FI. Narovlyansky AN, et al. Among authors: mezentseva mv. Russ J Immunol. 2000 Jul;5(2):185-192. Russ J Immunol. 2000. PMID: 12687174

5

Analysis of the interferon status and cytokine profile in patients with genital herpes.

Mezentseva MV, Narovlyansky AN, Scherbenko VE, Polonsky VO, Anokhina EY, Ershov FI. Mezentseva MV, et al. Russ J Immunol. 2002 Jul;7(2):167-74. Russ J Immunol. 2002. PMID: 12687260

6

Dynamics of Interferon System State Parameters during the Immune Therapy of Multiple Sclerosis: Individual Analysis.

Cheknev SB, Kobyakina NA, Mezentseva MV, Chekneva NS, Skvortsova VI. Cheknev SB, et al. Russ J Immunol. 2000 Dec;5(4):399-406. Russ J Immunol. 2000. PMID: 12687195

7

Long-Term Study of Interferon System State in Patients with Multiple Sclerosis Received the Individual Immune Therapy with Human Recombinant IFN-alpha.

Cheknev SB, Kobyakina NA, Mezentseva MV, Skvortsova VI. Cheknev SB, et al. Russ J Immunol. 2001 Apr;6(1):39-46. Russ J Immunol. 2001. PMID: 12687205

8

Possibility for Combination of Human rIFN-alpha and rIFN-beta in Complex Immune Therapy of Multiple Sclerosis.

Cheknev SB, Kobyakina NA, Mezentseva MV, Chekneva NS, Skvortsova VI. Cheknev SB, et al. Russ J Immunol. 2001 Oct;6(3):271-280. Russ J Immunol. 2001. PMID: 12687227

9

A potential new biological marker of the biological age.

Zuev VA, Mezentseva MV, Schaposchnikova GM. Zuev VA, et al. Among authors: mezentseva mv. Front Genet. 2013 Oct 24;4:198. doi: 10.3389/fgene.2013.00198. eCollection 2013. Front Genet. 2013. PMID: 24167518 Free PMC article. No abstract available.

10

In Vitro Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2.

Narovlyansky AN, Filimonova MV, Tsyshkova NG, Pronin AV, Grebennikova TV, Karamov EV, Larichev VF, Kornilayeva GV, Fedyakina IT, Dolzhikova IV, Mezentseva MV, Isaeva EI, Poloskov VV, Koval LS, Marinchenko VP, Surinova VI, Filimonov AS, Shitova AA, Soldatova OV, Sanin AV, Zubashev IK, Ponomarev AV, Veselovsky VV, Kozlov VV, Stepanov AV, Khomich AV, Kozlov VS, Ivanov SA, Shegai PV, Kaprin AD, Ershov FI, Gintsburg AL. Narovlyansky AN, et al. Among authors: mezentseva mv. Acta Naturae. 2023 Oct-Dec;15(4):83-91. doi: 10.32607/actanaturae.26623. Acta Naturae. 2023. PMID: 38234608 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page